1-(5-(4-chlorophenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-2-(5-p-tolyl-1,3,4-oxadiazol-2-ylthio)ethanone

ID: ALA4526118

PubChem CID: 155543337

Max Phase: Preclinical

Molecular Formula: C24H19ClN4O2S2

Molecular Weight: 495.03

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2nnc(SCC(=O)N3N=C(c4cccs4)CC3c3ccc(Cl)cc3)o2)cc1

Standard InChI:  InChI=1S/C24H19ClN4O2S2/c1-15-4-6-17(7-5-15)23-26-27-24(31-23)33-14-22(30)29-20(16-8-10-18(25)11-9-16)13-19(28-29)21-3-2-12-32-21/h2-12,20H,13-14H2,1H3

Standard InChI Key:  IMAMIWADQYFCJX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   13.3543  -12.8439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3531  -13.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0612  -14.0724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7709  -13.6630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7680  -12.8403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0594  -12.4350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6451  -14.0715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4738  -12.4266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2216  -12.7561    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7661  -12.1467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3548  -11.4405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5562  -11.6136    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5791  -12.2291    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   18.0570  -11.5662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8700  -11.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3478  -10.9856    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2052  -12.3938    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1611  -10.9792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4107  -10.2010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7477   -9.7232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0885  -10.2061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3135   -9.9601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1403   -9.1603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3625   -8.9119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7573   -9.4623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9350  -10.2643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7126  -10.5089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1872   -9.9416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8501  -10.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5095   -9.9366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2540   -9.1603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4368   -9.1635    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.9784   -9.2151    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  2  0
  5  8  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 21 22  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 28  1  0
 19 28  1  0
 25 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4526118

    ---

Associated Targets(Human)

U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ASPC1 (1310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 495.03Molecular Weight (Monoisotopic): 494.0638AlogP: 6.23#Rotatable Bonds: 6
Polar Surface Area: 71.59Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.61CX LogD: 5.61
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.30Np Likeness Score: -2.31

References

1. Fernandes GFDS, Fernandes BC, Valente V, Dos Santos JL..  (2019)  Recent advances in the discovery of small molecules targeting glioblastoma.,  164  [PMID:30583248] [10.1016/j.ejmech.2018.12.033]
2. Nehra B, Rulhania S, Jaswal S, Kumar B, Singh G, Monga V..  (2020)  Recent advancements in the development of bioactive pyrazoline derivatives.,  205  [PMID:32795767] [10.1016/j.ejmech.2020.112666]

Source